Results 71 to 80 of about 70,616 (253)
Characteristics of Patients with Idiopathic Bronchiectasis in Comparison to Post-infectious Bronchiectasis in South Korea [PDF]
Background Bronchiectasis has a complex and heterogeneous pathogenesis, with various etiologies, the majority being idiopathic. This study aimed to examine the characteristics of patients with idiopathic bronchiectasis in comparison to those with post ...
Seo-Young Hwang +5 more
doaj +1 more source
Background: Gastro-oesophageal reflux disease (GORD) is not only a common aetiology but also accompanying comorbidity of non-cystic fibrosis bronchiectasis (bronchiectasis).
Jai Hoon Yoon +9 more
doaj +1 more source
Bronchiectasis Cough During the COVID-19 Pandemic: A Qualitative Study [PDF]
aim: Cough and airway secretions are part of daily life for people living with bronchiectasis. During the COVID-19 pandemic, infections associated with airway inflammation and cough amplified the health-related stigma and social unacceptability of ...
McRae, Wendy +3 more
core +1 more source
Measuring airway clearance outcomes in bronchiectasis: a review
While airway clearance techniques (ACTs) are recommended for individuals with bronchiectasis, many trials have demonstrated inconsistent benefits or failed to reach their primary outcome.
Morris, Norman R +10 more
core +1 more source
Advancing Therapies for Mycobacterial Diseases: From Small Molecules to Host‐Directed Strategies
ABSTRACT The global burden of multidrug‐resistant tuberculosis (MDR‐TB) and the rising incidence of nontuberculous mycobacterial (NTM) infections highlight the urgent need for innovative therapeutic strategies. Current treatments are prolonged, toxic, and increasingly compromised by resistance and limited diagnostic capacity.
Tânia Silva +23 more
wiley +1 more source
Inhaled non-steroid anti-inflammatories for children and adults with bronchiectasis (Review) [PDF]
Free to read\ud \ud Plain language summary:\ud \ud Inhaled non-steroid anti-inflammatories (NSAIDs) for children and adults with bronchiectasis\ud \ud People with bronchiectasis experience chronic inflammation of the lungs.
Upham, John W. +14 more
core +1 more source
Potential of Ginkgo biloba Extract to Intervene in Chronic Inflammation‐Related Diseases
Chronic inflammation is a pathological mechanism underpinning many diseases. Ginkgo biloba extract (GBE) is well known for its anti‐inflammatory property. GBE and its active constituents have been shown to attenuate pro‐inflammatory cytokine production, suppress nuclear factor kappa B activation, restore redox homeostasis, and modulate disease‐relevant
Yipeng Lin +7 more
wiley +1 more source
Summary of pregnancy management in CTD‐ILD across preconception, antenatal, and postpartum phases, emphasizing risk stratification and multidisciplinary care. 6MWT, 6‐min walk test; CTD‐ILD: connective tissue disease‐interstitial lung disease; DLCO, diffusion capacity of the lung for carbon monoxide; FVC, forced vital capacity; MDT, multidisciplinary ...
Khaled Aldhuaina +3 more
wiley +1 more source
Secondary Immunodeficiency and Non-cystic Fibrosis Bronchiectasis [PDF]
Bronchiectasis is a chronic respiratory disease characterized by abnormal dilation of the bronchi that causes cough, sputum, and recurrent infections. As it may be associated with various respiratory or systemic diseases, a critical aspect of managing ...
Sungmin Zo +3 more
doaj +1 more source
AbstractBackground and aims: Bronchiectasis is defined as an abnormal and irreversible dilatation of the bronchi, often associated with chronic productive cough, airway obstruction, and recurrent infections.Methods: MEDLINE data from 1978 to November 2008 was analysed.
M. Pappalettera +5 more
openaire +3 more sources

